Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levocetirizine (2.5mg) + Montelukast (4mg) Bilayered
Therapeutic Category
Asthma, General and OTC medicines, Pulmonary, Respiratory, Antihistamines
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹82/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Monclip LC Kid Tablet is a dual-action, bilayered tablet formulated with Levocetirizine (2.5mg) and Montelukast (4mg), specifically designed for children to provide effective relief from allergy symptoms and respiratory issues. This combination is a potent solution for managing both allergic rhinitis and asthma in pediatric patients.
Levocetirizine is a third-generation antihistamine that blocks the action of histamine, a chemical in the body responsible for allergic reactions. It helps alleviate symptoms like sneezing, runny nose, itchy or watery eyes, and itching of the throat or nose caused by allergies. Unlike older antihistamines, Levocetirizine has minimal sedative effects, making it suitable for children who need to stay active and focused during the day.
Montelukast is a leukotriene receptor antagonist that works by blocking the effects of leukotrienes, chemicals involved in the inflammation and constriction of airways in conditions like asthma. By reducing these effects, Montelukast helps prevent asthma attacks and improves respiratory function, making it easier for children to breathe.
The bilayered design of Monclip LC Kid Tablet ensures the sustained release of these two active ingredients, providing prolonged relief throughout the day and improving the convenience of treatment for both children and their caregivers. This combination tablet is designed to manage asthma symptoms and allergic conditions effectively, reducing the frequency of asthma attacks and minimizing allergic reactions in children.
Common side effects may include: Drowsiness or fatigue Dry mouth Headache Stomach upset or diarrhea Serious side effects are rare but may include: Allergic reactions (rash, swelling, difficulty breathing) Behavioral changes, irritability, or mood swings If side effects persist or worsen, consult a healthcare provider.
Management of allergic rhinitis in children, reducing symptoms like sneezing, runny nose, and itching. Prevention and treatment of asthma in children, helping to reduce airway inflammation and bronchoconstriction.
This product is intended for children and should be used under the supervision of a healthcare provider. Not recommended for children under the age of 2. May cause drowsiness in some children; caution should be taken when engaging in activities requiring alertness. Should not be used in combination with other sedatives unless advised by a doctor.
Store at room temperature (15°C to 25°C). Keep in a tightly closed container away from light, heat, and moisture. Keep out of reach of children.
Composition : Levocetirizine (5mg) + Montelukast (10mg) Bilayered
Composition : Chlorpheniramine Maleate (2mg) + Paracetamol (500mg) + Phenylephrine (10mg)
Composition : Cetirizine (10mg) Tablet
Composition : Bilastine (10mg) tablet
Composition : Bilastine (20mg) Tablet
Composition : Montelukast (10mg) + Fexofenadine (120mg)
Composition : Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg) (Sustained Release)
Composition : Cinnarizine (25mg)
Composition : Phenylephrine (5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (10mg)
Composition : Hydroxyzine (10mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Levocetirizine + Montelukast Tablet is used for allergic rhinitis, seasonal allergies, bronchial asthma, sneezing, runny nose, and other respiratory allergic conditions. It is a strong respiratory and anti-allergic segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in ENT clinics, pediatric practices, general physicians, and respiratory specialists. It is widely prescribed for long-term allergy control and asthma-related symptoms, ensuring steady prescription cycles.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory and anti-allergic formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong seasonal demand, pediatric and adult prescriptions, repeat purchases, and high retail movement in allergy and respiratory segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.